EKNL Stock Overview
EKO International Corp., through its joint venture interest in NeuroVasc Clinical Inc., promotes and distributes frequency rhythmic electrical modulation system equipment used in the treatment of peripheral neuropathy in Canada.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
EKO International Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.00001 |
| 52 Week High | US$0.0002 |
| 52 Week Low | US$0.00001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | -95.00% |
| 3 Year Change | -99.91% |
| 5 Year Change | -99.50% |
| Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| EKNL | US Commercial Services | US Market | |
|---|---|---|---|
| 7D | 0% | 2.2% | 3.3% |
| 1Y | -95.0% | 26.1% | 25.0% |
Return vs Industry: EKNL underperformed the US Commercial Services industry which returned 26.1% over the past year.
Return vs Market: EKNL underperformed the US Market which returned 25% over the past year.
Price Volatility
| EKNL volatility | |
|---|---|
| EKNL Average Weekly Movement | n/a |
| Commercial Services Industry Average Movement | 7.5% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: EKNL has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine EKNL's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | n/a | n/a |
EKO International Corp., through its joint venture interest in NeuroVasc Clinical Inc., promotes and distributes frequency rhythmic electrical modulation system equipment used in the treatment of peripheral neuropathy in Canada. The company, through its joint venture interest in NeuroVasc Clinical Inc., also sets up and/or manage clinics to treat patients using FREMSTM equipment. EKO International Corp. is based in Burlington, Canada.
EKO International Corp. Fundamentals Summary
| EKNL fundamental statistics | |
|---|---|
| Market cap | US$316.00 |
| Earnings (TTM) | US$30.88k |
| Revenue (TTM) | n/a |
0.0x
P/E Ratio0.0x
P/S RatioIs EKNL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| EKNL income statement (TTM) | |
|---|---|
| Revenue | -US$970.19k |
| Cost of Revenue | -US$431.59k |
| Gross Profit | -US$538.60k |
| Other Expenses | -US$569.48k |
| Earnings | US$30.88k |
Last Reported Earnings
Mar 31, 2011
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did EKNL perform over the long term?
See historical performance and comparison